Emer Joyce, MB BCh BAO, PhD - Staying Ahead of the Curve in ATTR-CM: Adapting and Advancing Our Approach to Decision-Making as the Treatment Landscape Evolves

Visit https://www.peervoice.com/FMW860 to view the entire programme with slides. After completing “Emer Joyce, MB BCh BAO, PhD - Staying Ahead of the Curve in ATTR-CM: Adapting and Advancing Our Approach to Decision-Making as the Treatment Landscape Evolves”, participants will be able to: Assess available data which may be applied to guide treatment decision-making within the evolving treatment landscape of transthyretin amyloid cardiomyopathy (ATTR-CM); Differentiate between TTR stabilisers based on existing evidence in ATTR-CM; and Apply current evidence related to the use of combination therapy in patients with ATTR-CM.

Listen